{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-016105","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2021-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.210822+00:00","generated_at":"2026-06-30T07:48:00.565245+00:00","sec_items":["1.01","3.02","5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oncotelic extends note maturity to March 2022, issues 22M warrants, CTO Park resigns","bullets":["Issued $103,750 convertible promissory note to Geneva Roth Remark Holdings on June 28, 2021.","Extended maturity of JH Darbie financing notes from June 30, 2021 to March 31, 2022.","Issued 20M additional Oncotelic warrants to investors and 2M warrants to placement agent J.H. Darbie & Co.","CTO Chulho Park resigned effective July 1, 2021 due to personal health; will continue as part-time consultant."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-016105","json":"https://secwatch.observer/filing/0001493152-21-016105.json","markdown":"https://secwatch.observer/filing/0001493152-21-016105.md","text":"https://secwatch.observer/filing/0001493152-21-016105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/0001493152-21-016105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T07:48:00.565245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d6b5e58f24","claim":"Chulho Park resigned as Chief Technology Officer at Oncotelic Therapeutics, Inc..","evidence_excerpt":"On July 1, 2021, Chulho Park, Ph. D., provided notice to the Company of his intention to resign as the Chief Technology Officer of the Company, to be effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/908259/000149315221016105/0001493152-21-016105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Technology Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}